University of Alabama at Birmingham
Kevin Riggs
The goal of this clinical trial is to develop an pharmacist-led preoperative opioid taper intervention for patients undergoing total knee or hip replacement who are on chronic opioids before their surgery. The main questions it aims to answer are: * Is the intervention feasible and acceptable to patients? * Does the intervention result in a decrease in opioid dose during the preoperative period? Participants will meet with a clinical pharmacist, who will provide some basic education on pain and opioids, and will propose an opioid taper schedule. The pharmacist will then follow-up with the participant by phone each week until surgery to assess progress and adjust the taper as necessary.
Arthritis Knee
Arthritis Hip
Chronic Pain
opioid taper
NA
| Study Type : | INTERVENTIONAL |
| Estimated Enrollment : | 45 participants |
| Masking : | NONE |
| Primary Purpose : | SUPPORTIVE_CARE |
| Official Title : | Developing and Testing an Opioid Taper Intervention Before Total Knee Arthroplasty: Phase 2 Intervention Development |
| Actual Study Start Date : | 2024-01-10 |
| Estimated Primary Completion Date : | 2025-03-03 |
| Estimated Study Completion Date : | 2025-03-03 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 18 Years |
| Sexes Eligible for Study: | ALL |
| Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
UAB Hospital-Highlands
Birmingham, Alabama, United States, 35205